News Could an AI for biological age guide cancer treatment? Researchers have developed an AI that could help doctors predict a patient's chance of surviving cancer – and potentially guide treatment decisions.
R&D Sponsored The importance of time: Grifols seeks biomarkers for early d... Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.
Digital Balancing innovation and efficiency in clinical trials: Is t... Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes
News Takeda backs biomarker trial for Crohn's prevention The INTERCEPT trial aims to validate biomarkers that could identify people at risk of Crohn's and see if treatment can prevent symptoms developing.
News Grifols gets $21m award for Parkinson's biomarker hunt Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start.
R&D The role of bioanalysis as the foundation of precision medic... Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.